Prophase Labs

Prophase Labs EBIT/Assets

The Operating Income to Assets Ratio (EBIT/Assets) of Prophase Labs (PRPH) as of Oct 16, 2026 is -30.14 %. In the previous year, Operating Income to Assets Ratio (EBIT/Assets) was -61.12 % — a change of -50.68% (higher).

EBIT/Assets

-30.14 %

YoY

-50.68%

Last updated:

Operating Income to Assets Ratio (EBIT/Assets) of Prophase Labs is 2025 -30.14 % . Operating Income to Assets Ratio (EBIT/Assets) of Prophase Labs was 2024 -61.12 % . It decreases by -50.68% higher compared to the previous year.

The Prophase Labs EBIT/Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT/Assets
Date
EBIT/Assets
Jan 1, 2018
-7.88 USD
Jan 1, 2019
-26.39 USD
Jan 1, 2020
-12.65 USD
Jan 1, 2021
10.98 USD
Jan 1, 2022
26.92 USD
Jan 1, 2023
-23.51 USD
Jan 1, 2024
-61.12 USD
Jan 1, 2025
-30.14 USD
The Prophase Labs EBIT/Assets history
YEAREBIT/AssetsYoY
-30.14 %-50.68%
-61.12 %+159.97%
-23.51 %-187.34%
26.92 %+145.26%
10.98 %-186.76%
-12.65 %-52.06%
-26.39 %+234.90%
-7.88 %-32.54%
-11.68 %-43.70%
-20.75 %-14.16%
-24.17 %-50.42%
-48.75 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Prophase Labs Stock analysis

What does Prophase Labs do? ProPhase Labs Inc, based in New York City, operates in the Health Care sector, specializing in pharmaceuticals. The company develops, manufactures, and markets over-the-counter consumer healthcare products and dietary supplements, including TK Supplements and ORXx Complete. Its product range features LEGENDZ XL for male enhancement, TRIPLE EDGE XL for energy, and ORXx cough/cold drops. ProPhase Labs serves national wholesalers, distributors, and retail chains in food, drug, and mass merchandise sectors. Prophase Labs is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Prophase Labs stock

Operating Income to Assets Ratio (EBIT/Assets) of Prophase Labs is -30.14 % in 2025.

Operating Income to Assets Ratio (EBIT/Assets) of Prophase Labs changed from -61.12 % to -30.14 %, representing a -50.68% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Income to Assets Ratio (EBIT/Assets) Prophase Labs since 2006 – with annual values, charts, and detailed analysis.

EBIT/Assets measures operating profitability relative to total assets, providing an unlevered view of asset efficiency that is comparable across capital structures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Income to Assets Ratio (EBIT/Assets)'s Prophase Labs with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Income to Assets Ratio (EBIT/Assets)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Income to Assets Ratio (EBIT/Assets).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Prophase Labs

All Key Metrics — Prophase Labs